Literature DB >> 17877504

Review article: renal function assessment in cirrhosis - difficulties and alternative measurements.

E Cholongitas1, V Shusang, L Marelli, D Nair, M Thomas, D Patch, A Burns, P Sweny, A K Burroughs.   

Abstract

BACKGROUND: Renal function in patients with cirrhosis is important prognostically, both before and following liver transplantation. Its prognostic impact is reflected by the inclusion of serum creatinine in the model for end-stage liver disease score, which is now used for recipient prioritization on liver transplantation waiting lists in the USA. AIM: To review the accuracy of the surrogate markers for the assessment of renal function, i.e. glomerular filtration rate, particularly in patients with cirrhosis.
METHOD: We reviewed the available literature in PubMed regarding the markers for GFR evaluation and the factors which affect their accuracy in cirrhosis.
RESULTS: Although creatinine is widely available, it is an unreliable marker of glomerular filtration rate, particularly in patients with cirrhosis. Clearance of exogenous markers is considered the 'gold standard', but this methodology has many drawbacks, particularly poor applicability. Several mathematical formulae for estimated glomerular filtration rate are used to overcome some of these limitations: Cockcroft-Gault and Modification of Diet in Renal Disease formulae are the most frequently applied, but they are based on serum creatinine.
CONCLUSIONS: Due to the inaccuracy of serum creatinine and its derived formulae in estimating glomerular filtration rate, alternative serum markers, such as cystatin C, and new formulae are desirable. These need formal evaluation in patients with cirrhosis so as to have a reliable surrogate of glomerular filtration rate, and to obviate many problems that are associated with using creatinine and estimated glomerular filtration rate.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17877504     DOI: 10.1111/j.1365-2036.2007.03443.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  42 in total

Review 1.  Kidney Failure and Liver Allocation: Current Practices and Potential Improvements.

Authors:  Varun Saxena; Jennifer C Lai
Journal:  Adv Chronic Kidney Dis       Date:  2015-09       Impact factor: 3.620

2.  The impact of MELD allocation on simultaneous liver-kidney transplantation.

Authors:  Julie A Thompson; John R Lake
Journal:  Curr Gastroenterol Rep       Date:  2009-02

Review 3.  Prioritization for liver transplantation.

Authors:  Evangelos Cholongitas; Giacomo Germani; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

4.  Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.

Authors:  Zhi-Hong Wan; Jian-Jun Wang; Shao-Li You; Hong-Ling Liu; Bing Zhu; Hong Zang; Chen Li; Jing Chen; Shao-Jie Xin
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 5.  Liver involvement in kidney disease and vice versa.

Authors:  Karen Van Hoeve; Djalila Mekahli; Eva Morava; Elena Levtchenko; Peter Witters
Journal:  Pediatr Nephrol       Date:  2017-06-23       Impact factor: 3.714

6.  Plasma Levels of Uric Acid, Urea and Creatinine in Diabetics Who Visit the Clinical Analysis Laboratory (CAn-Lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Authors:  N A A Amartey; K Nsiah; F O Mensah
Journal:  J Clin Diagn Res       Date:  2015-02-01

7.  Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis.

Authors:  Yu-Wei Chen; Han-Hsiang Chen; Tsang-En Wang; Ching-Wei Chang; Chen-Wang Chang; Chih-Jen Wu
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

Review 8.  Renal dysfunction in chronic liver disease.

Authors:  Andy Slack; Andrew Yeoman; Julia Wendon
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

9.  Risk factors for acute kidney injury following orthotopic liver transplantation: the impact of changes in renal function while patients await transplantation.

Authors:  Jose I Iglesias; John A DePalma; Jerrold S Levine
Journal:  BMC Nephrol       Date:  2010-11-08       Impact factor: 2.388

Review 10.  [Model for end-stage liver disease. New basis of allocation for liver transplantations].

Authors:  G E Jung; J Encke; J Schmidt; A Rahmel
Journal:  Chirurg       Date:  2008-02       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.